86386 Nuclear matrix protein 22
Pathology & Lab
Also known as: NMP22, nuclear matrix protein 22
Nuclear matrix protein 22 detection measuring tumor-associated antigen presence in urine, used as a tumor marker for bladder cancer screening.
Clinical Context
Detects nuclear matrix protein 22 in urine as marker for bladder cancer. Useful for surveillance of patients with history of transitional cell carcinoma and screening of patients with hematuria.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.